Katerji M, Bertucci A, Filippov V, Vazquez M, Chen X, Duerksen-Hughes P
Front Oncol. 2022; 12:928545.
PMID: 36119491
PMC: 9478911.
DOI: 10.3389/fonc.2022.928545.
Habiba U, Hossain E, Yanagawa-Matsuda A, Chowdhury A, Tsuda M, Zaman A
Cancers (Basel). 2020; 12(4).
PMID: 32230919
PMC: 7226092.
DOI: 10.3390/cancers12040809.
Zelensky A, Schoonakker M, Brandsma I, Tijsterman M, van Gent D, Essers J
PLoS Genet. 2020; 16(1):e1008550.
PMID: 31945059
PMC: 6964834.
DOI: 10.1371/journal.pgen.1008550.
Alizadeh Zarei M, Takhshid M, Behzad Behbahani A, Hosseini S, Okhovat M, Rafiee Dehbidi G
J Biomed Phys Eng. 2017; 7(3):257-264.
PMID: 29082216
PMC: 5654131.
Fujita T, Satoh T, Timme T, Hirayama T, Zhu J, Kusaka N
Urol Oncol. 2013; 32(2):92-100.
PMID: 23433894
PMC: 3871954.
DOI: 10.1016/j.urolonc.2012.10.007.
Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.
Kaur R, Chen S, Arevalo M, Xu Q, Chen Y, Zeng M
Clin Vaccine Immunol. 2012; 19(3):359-64.
PMID: 22278325
PMC: 3294612.
DOI: 10.1128/CVI.05384-11.
Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells.
Zhou H, Yin Y, Hu Y, Li X, Zou L, Li Y
Jpn J Radiol. 2011; 29(9):615-22.
PMID: 21956366
DOI: 10.1007/s11604-011-0603-9.
Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.
Sharma A, Bangari D, Vemula S, Mittal S
Virus Res. 2011; 161(2):181-7.
PMID: 21864589
PMC: 3197224.
DOI: 10.1016/j.virusres.2011.08.002.
Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts.
Wang H, Song X, Zhang H, Zhang J, Shen X, Zhou Y
Int J Cancer. 2011; 130(2):443-53.
PMID: 21351100
PMC: 3118272.
DOI: 10.1002/ijc.26013.
Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.
Geletneky K, Hartkopf A, Krempien R, Rommelaere J, Schlehofer J
J Biomed Biotechnol. 2010; 2010:350748.
PMID: 20224643
PMC: 2833303.
DOI: 10.1155/2010/350748.
High-efficiency transfer and expression of AdCMV-p53 in human cervix adenocarcinoma cells induced by subclinical-dose carbon beam radiation.
Liu B, Zhang H, Luo X, Xie Y, Hao J, Zhou Q
J Cancer Res Clin Oncol. 2008; 135(7):925-32.
PMID: 19085001
DOI: 10.1007/s00432-008-0528-6.
Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
Inoue H, Iga M, Nabeta H, Yokoo T, Suehiro Y, Okano S
Cancer Sci. 2008; 99(11):2315-26.
PMID: 18957055
PMC: 11159209.
DOI: 10.1111/j.1349-7006.2008.00964.x.
Adenovirus-mediated p53 gene transfer sensitizes hepatocellular carcinoma cells to heavy-ion radiation.
Liu B, Zhang H, Zhou G, Xie Y, Hao J, Qiu R
J Gastroenterol. 2007; 42(2):140-5.
PMID: 17351803
DOI: 10.1007/s00535-006-1977-9.
Adenoviral gene therapy, radiation, and prostate cancer.
Lupold S, Rodriguez R
Rev Urol. 2006; 7(4):193-202.
PMID: 16985830
PMC: 1550784.
Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma.
Chang J, Zhang X, Komaki R, Cheung R, Fang B
Int J Radiat Oncol Biol Phys. 2006; 64(5):1482-94.
PMID: 16580499
PMC: 1458528.
DOI: 10.1016/j.ijrobp.2005.11.045.
Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
Zhang X, Cheung R, Komaki R, Fang B, Chang J
Clin Cancer Res. 2005; 11(18):6657-68.
PMID: 16166445
PMC: 1351100.
DOI: 10.1158/1078-0432.CCR-04-2699.
A capsid-modified helper-dependent adenovirus vector containing the beta-globin locus control region displays a nonrandom integration pattern and allows stable, erythroid-specific gene expression.
Wang H, Shayakhmetov D, Leege T, Harkey M, Li Q, Papayannopoulou T
J Virol. 2005; 79(17):10999-1013.
PMID: 16103151
PMC: 1193620.
DOI: 10.1128/JVI.79.17.10999-11013.2005.
Current status of tumor radiogenic therapy.
Min F, Zhang H, Li W
World J Gastroenterol. 2005; 11(20):3014-9.
PMID: 15918182
PMC: 4305832.
DOI: 10.3748/wjg.v11.i20.3014.
Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.
Gowardhan B, Douglas D, Mathers M, McKie A, McCracken S, Robson C
Br J Cancer. 2005; 92(2):320-7.
PMID: 15655558
PMC: 2361833.
DOI: 10.1038/sj.bjc.6602274.
Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy.
Collis S, Khater K, DeWeese T
World J Urol. 2003; 21(4):275-89.
PMID: 12920560
DOI: 10.1007/s00345-003-0363-y.